1-Year Outcomes of Lung Transplantation for Coronavirus Disease 2019-Associated End-Stage Lung Disease in the United States

Lung transplantation in COVID-19 patients with end-stage lung disease has proven to improve quality of life and be a viable treatment option. This study confirmed that by comparing a group of COVID-associated transplant patients with a group of patients needing transplants for other reasons. Although they had longer hospital stays, the COVID-related cases had a similar one-year survival rate to the other cohort.